Skip to main content
. 2022 Nov 20;11(11):2297. doi: 10.3390/antiox11112297

Table 1.

Anthropometric and biochemical parameters.

Control T2D p-Value BMI Adjusted p-Value
n 57 51
Age (years) 53.7 ± 7.7 57.10 ± 10.3 NS
Weight (kg) 72.8 ± 18.0 84.7 ± 16.4 <0.001
BMI (kg/m2) 25.7 ± 4.14 30.6 ± 5.48 <0.001
Waist (cm) 87.7 ± 12.7 103.5± 11.7 <0.001
Glucose (mg/dL) 94.1 ± 9.4 153.7± 45.0 *** <0.001 <0.001
Insulin (μL/mL) 7.19± 2.62 25.9± 15.7 *** <0.001 <0.001
HOMA-IR 1.67 ± 0.70 9.74 ± 6.87 *** <0.001 <0.001
HbA1c (%) 5.31 ± 0.34 7.14 ± 1.16 *** <0.001 <0.001
TC (mg/dL) 203.7 ± 34.5 158.7 ± 39.1 *** <0.001 <0.001
HDL-c (mg/dL) 57.2 ± 19.7 43.5 ± 9.85 ** <0.001 <0.003
LDL-c (mg/dL) 126.5 ± 29.5 87.0 ± 31.7 *** <0.001 <0.001
TG (mg/dL) 90.5 (62.8–150.5) 132 (92.8–164.75) ** <0.009 NS
Hs-CRP (mg/L) 1.17 (0.44–2.17) 2.45 (1.22–5.39) <0.001 NS

Values are expressed as mean ± standard deviation for parametric data and as median (25th and 75th percentiles) for non-parametric data. The three groups were compared with one-way analysis of variance (and Student–Newman–Keuls post hoc test) or the Kruskal–Wallis test (and Dunn’s multiple-comparison post hoc test) for parametric and non-parametric data, respectively. The analysis of covariance was performed with a univariate general linear model using the BMI as a covariate. ** p < 0.01 and *** p < 0.001 with respect to control. Abbreviations: BMI, body–mass index; HbA1c, glycated haemoglobin A1c; HDL-c, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment of insulin resistance; hs-CRP, highsensitive C-reactive protein; LDL-c, low-density lipoprotein cholesterol; T2D, type 2 diabetes; TC, total cholesterol; TG, triglycerides; NS: not significant.